USPTO Says Novartis' Patent Term Case Is Time-Barred

Law360, Los Angeles (June 19, 2012, 4:52 PM ET) -- The U.S. Patent and Trademark Office on Monday asked a Washington federal court to block Novartis AG's bid to extend patent term adjustments the drugmaker claims unfairly cut short 23 patents, arguing Novartis' lawsuit is time-barred.

The USPTO said in a motion seeking to nix Novartis' suit that the drugmaker isn't entitled to a recalculation of its patent terms in accordance with the Federal Circuit's landmark ruling in Wyeth v. Kappos because too much time has passed since most of the patents-in-suit were issued.

In Wyeth,...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

NOVARTIS AG et al v. KAPPOS


Case Number

1:10-cv-01138

Court

District Of Columbia

Nature of Suit

Patent

Judge

Ellen S. Huvelle

Date Filed

July 6, 2010

Law Firms

Companies

Government Agencies

Patents

DEWEY LIVE BLOG

Follow our exclusive coverage of the trial of the year:

Dewey Trial Day 34: The Fiancee